Evidence map›Paper›PMID 22631052›Full record

ArticleACS nano2012

Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy.

Jian Wang, Guizhi Zhu, Mingxu You, Erqun Song, Mohammed Ibrahim Shukoor, Kejing Zhang, Meghan B Altman, Yan Chen, Zhi Zhu, Cheng Zhi Huang and 1 more

Abstract read
In one paragraph

Article in ACS nano, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 358 citations in OpenAlex.

  1. Review
  2. Review
  3. Aptamers in Drug Delivery Development.Materials today (Kidlington, England) · 2025
    Article
  4. Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Rationally Designed DNA-Based Scaffolds and Switching Probes for Protein Sensing.Advances in biochemical engineering/biotechnology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Biological Synthesis of Bioactive Gold Nanoparticles fromInternational journal of molecular sciences · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jian WangDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/Nano, UF Genetics Institute and McKnight Brain Institute, University of Florida, Gainesville, Florida 32611-7200, USA.
Guizhi Zhu
Mingxu You
Erqun Song
Mohammed Ibrahim Shukoor
Kejing Zhang
Meghan B Altman
Yan Chen
Zhi Zhu
Cheng Zhi Huang
Weihong Tan
Interface (United States) · USUniversity of Florida Health · USSouthwest University · CNState Key Laboratory of Chemobiosensing and Chemometrics

Funding

UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Development of molecular probes for biomedical applicationsR01GM079359 · NIGMS · UNIVERSITY OF FLORIDA · PI TAN, WEIHONG · 2007 to 2016
$2.3M
Molecular Beacon Aptamer for Diagnostic Cancer ImagingR21CA092581 · NCI · UNIVERSITY OF FLORIDA · PI TAN, WEIHONG · 2002 to 2003
$286k
NCATS NIH HHS UL1 TR000064NCI NIH HHS R21 CA092581NIGMS NIH HHS R01 GM079359
6 · The paper itself

Abstract

An aptamer switch probe (ASP) linking chlorin e6 (Ce6), a photosensitizer molecule, to the surface of gold nanorods (AuNRs) was used to target cancer cells for photodynamic therapy (PDT) and photothermal therapy (PTT). In the presence of target cancer cells, the ASP changes conformation to drive Ce6 away from the gold surface, thereby producing singlet oxygen for PDT upon light irradiation. Since each AuNR is modified with many ASP-Ce6 molecules, the AuNR-ASP-Ce6 conjugate yields enhanced binding and therapeutic effect by the added ability to carry many photosensitizers. In addition, absorption of radiation by the gold nanorods enables further cell destruction by the photothermal effect. Consequently, this multimodal AuNR-ASP-Ce6 conjugate offers a remarkably improved and synergistic therapeutic effect compared to PTT or PDT alone, providing high specificity and therapeutic efficiency, which can be generalized to other types of cancer therapies.

Indexed as

AnimalsAptamers, PeptideCell Line, TumorChlorophyllidesDrug Delivery SystemsGoldHyperthermia, InducedMiceNanotubesNeoplasms, ExperimentalPhotochemotherapyPhotosensitizing AgentsPorphyrinsTreatment OutcomeAptamers, PeptideChlorophyllidesGoldPhotosensitizing AgentsphytochlorinPorphyrins

Identifiers

PMID22631052
PMCPMC3407577
OpenAlexW2128565250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.